International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease
Frits van Rhee(Winthrop Rockefeller Foundation), David C. Fajgenbaum(University of Pennsylvania), Joshua D. Brandstadter(University of Pennsylvania), Makoto Ide(Takamatsu Red Cross Hospital), Kojo S.J. Elenitoba‐Johnson(Memorial Sloan Kettering Cancer Center), Sophia A. T. Parente(University of Pennsylvania), Shanmuganathan Chandrakasan(Emory University), Megan S. Lim(Memorial Sloan Kettering Cancer Center), Nikhil C. Munshi(Dana-Farber Cancer Institute), Ivan Maillard(University of Michigan), Thomas S. Uldrick(Regeneron (United States)), Razelle Kurzrock(Medical College of Wisconsin), Alexander Fosså(Oslo University Hospital), Sheila K. Pierson(University of Pittsburgh Medical Center), Raymond Wong(Chinese University of Hong Kong), Kazuyuki Yoshizaki(Osaka Research Institute of Industrial Science and Technology), Amy D Greenway(University of Arkansas for Medical Sciences), Matthew Streetly(King's College - North Carolina), Amy Chadburn(Cornell University), Wilbur B. Bowne(Thomas Jefferson University), Gordan Srkalović(Regional Cancer Center), Peter M. Voorhees(Levine Cancer Institute), Mary Jo Lechowicz(Emory University), Corey Casper(University of Washington), Sunita D. Nasta(University of Pennsylvania), David Wu(University of Washington), Angela Dispenzieri(Mayo Clinic), Stephen Schey(University College Hospital), Éric Oksenhendler(Université Paris Cité)
Cited by 218
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
|Molecular Cancer Therapeutics|2017|2.4k
PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy
|Molecular Cancer Therapeutics|2015|2.3k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
|New England Journal of Medicine|2019|1.7k